Trial Information
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
Inclusion Criteria:
- Histologically or cytologically confirmed diagnosis of NSCLC.
- normal serum bilirubin
- informed concent to participate in the study
Exclusion Criteria:
- anticoagulant therapy
- infectious disease
Type of Study:
Observational
Study Design:
Additional Descriptors: Convenience Sample, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Principal Investigator
Galit Sarig, Ph.D
Investigator Role:
Principal Investigator
Investigator Affiliation:
Rambam Health Care Campus
Authority:
Israel: Israeli Health Ministry Pharmaceutical Administration
Study ID:
Thrombosis and cancer.CTIL
NCT ID:
NCT00192829
Start Date:
June 2005
Completion Date:
Related Keywords:
- Non-Small Cell Lung Carcinoma
- Venous Thromboembolism
- Lung cancer
- Thrombosis
- Hypercoagulable
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Thromboembolism
- Venous Thromboembolism
- Venous Thrombosis